Biotech
Therapeutics, genomics, synthetic biology and the science powering it all.
Latest Biotech news
India Ranks Third in Global DNA Synthesis, Yet Lacks Rules to Screen Orders
Read at Bioengineer.org →Sharpening an essential tool for biotechnology
Read at Technology Org →ICAR-CRRI, Cuttack team develops AI-designed genome editors for plants
Read at Indian Council Of Agricultural Research →Plant Virus Proteins Can Disarm a Promising Crop Gene-Editing Tool, Study Finds
Read at Global Agriculture →Genscript Biotech Corporation (1548.HK) stock price, news, quote and history
Read at Yahoo Finance UK →Bio-technology-based seed systems and Zim’s quest for climate-resilient food security
Read at Herald.co.zw →From the knowledge base
ASHG: Long-Read Genomics Meets Clinical Data in PacBio, Verily Health AI Deal
A multi-year collaboration will connect PacBio's HiFi sequencing with Verily Pre, combining long-read genomic and clinical data for biomedical research and AI model development.
5 iced coffees we're bringing to a job interview
A viral post sparked debate around the professionalism of iced coffee. Explore the gallery for our five natural iced coffee picks sure to impress.
It will take more than data to improve traceability in the cotton supply chain
New research supported by Cotton Diaries explores the idea of "relational traceability" and making farmers a key source of intel.
Former MIT professor David Sabatini awarded $6M in defamation case
A Massachusetts jury awarded $6 million in damages to prominent biologist David Sabatini, years after sexual harassment allegations led to his ouster from MIT. Roughly five years ago, Sabatini brought the
How this plastic-free personal care brand tackles men's reproductive health
Learn about Old Salt Grooming's plastic-free product line paired with broader messaging around men's reproductive health and the environmental cost of personal care.
Antheia gets $80M conditional DOD loan to onshore to the US
Biosynthesis manufacturer Antheia has won a conditional loan of $80 million from the US Department of Defense to help boost the domestic production of generic drugs. "Over time, we aim to manufacture Antheia's full pipeline ...